Patents

US 10660857 B2: Bacterial compositions for prophylaxis and treatment of degenerative disease

Granted
2020-05-26
Filed
2011-05-19 application 13111105
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The disclosure provides an oral composition for reducing serum cholesterol, serum lipids, body fat, or atherogenic index or for prophylaxis or treatment of atherosclerosis, cardiovascular or cerebrovascular diseases, comprising a highly bsh active bacteria, isolate or supernatant thereof; wherein the highly bsh active bacteria degrades >50 μmol glycodeoxycholic acid (GDCA)/gram/hour and >2 μmol taurodeoxycholic acid (TDCA)/gram/hour when measured over 1 hour and 5 hours, respectively, or degrades >65 μmol GDCA/g/hr and >7 μmol TDCA/g/hr when measured over 30 minutes.

Source: PVGPATDIS, file of 2026-04-10 (ipg200526.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
UAS Laboratories LLC 3 patentsUS company or organizationWausau, WIUAS Laboratories LLC Form D issuer EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Satya PrakashBrossard, CA18PVGPATDIS, file of 2026-04-10
Mitchell Lawrence JonesMontréal, CA35PVGPATDIS, file of 2026-04-10
Christopher MartoniMontréal, CA1PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K9/1664PVGPATDIS, file of 2026-04-10
A23CDairy products, e.g. milk, butter or cheese; milk or cheese substitutes; preparation thereofA23C9/1234PVGPATDIS, file of 2026-04-10
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for; preparation or treatment thereofA23L33/135PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/16PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N1/20PVGPATDIS, file of 2026-04-10
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparationA23V2002/00PVGPATDIS, file of 2026-04-10
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganismsC12R2001/225PVGPATDIS, file of 2026-04-10
Y02ATechnologies for adaptation to climate changeY02A90/10PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-01-19Assignment
Assignment of assignor's interest
UAS LABORATORIES LLC signed 2020-12-28CHR. HANSEN A/S 2970 HOERSHOLM54959/75ECORSEXC, file of 2026-09-25
2014-12-03Assignment
Assignment of assignor's interest
MICROPHARMA LIMITED signed 2014-11-28UAS LABORATORIES LLC MADISON, WI34365/498ECORSEXC, file of 2026-09-25
2011-11-01Assignment
Assignment of assignor's interest
PRAKASH, SATYA signed 2011-09-19
JONES, MITCHELL LAWRENCE signed 2011-09-20
MARTONI, CHRISTOPHER signed 2011-09-20
MICROPHARMA LIMITED MONTREAL27154/584ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.